Introduction: Focal Cortical Dysplasias (FCDs) represent the most common etiology in pediatric drug-resistant focal epilepsies undergoing surgical treatment. The localization, extent and histopathological features of FCDs are considerably variable. Somatic mosaic mutations of genes that encode proteins in the PI3K-AKTmTOR pathway, which also includes the tuberous sclerosis associated genes TSC1 and TSC2, have been implicated in FCD type II in a substantial subset of patients. Surgery is the principal therapeutic option for FCD-related epilepsy. Advanced neurophysiological and neuroimaging techniques have improved surgical outcome and reduced the risk for postsurgical deficits. Pharmacological MTOR inhibitors are being tested in clinical trials and might represent an example of personalized treatment of epilepsy based on the known mechanisms of disease, used alone or in combination with surgery
Focal cortical dysplasia: an update on diagnosis and treatment / Guerrini, Renzo; Barba, Carmen. - In: EXPERT REVIEW OF NEUROTHERAPEUTICS. - ISSN 1473-7175. - ELETTRONICO. - (2021), pp. 1-12. [10.1080/14737175.2021.1915135]
Focal cortical dysplasia: an update on diagnosis and treatment
Guerrini, Renzo
Writing – Original Draft Preparation
;Barba, CarmenWriting – Original Draft Preparation
2021
Abstract
Introduction: Focal Cortical Dysplasias (FCDs) represent the most common etiology in pediatric drug-resistant focal epilepsies undergoing surgical treatment. The localization, extent and histopathological features of FCDs are considerably variable. Somatic mosaic mutations of genes that encode proteins in the PI3K-AKTmTOR pathway, which also includes the tuberous sclerosis associated genes TSC1 and TSC2, have been implicated in FCD type II in a substantial subset of patients. Surgery is the principal therapeutic option for FCD-related epilepsy. Advanced neurophysiological and neuroimaging techniques have improved surgical outcome and reduced the risk for postsurgical deficits. Pharmacological MTOR inhibitors are being tested in clinical trials and might represent an example of personalized treatment of epilepsy based on the known mechanisms of disease, used alone or in combination with surgeryI documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.